Upstart CT angiography eclipses cardiac MRI's rising star

Article

"Nobody thought about doing CT angiography. It just wasn't on the radar screen, although a few proponents said, 'Don't forget about us; we're working on interesting things here in the desert.'

"Nobody thought about doing CT angiography. It just wasn't on the radar screen, although a few proponents said, 'Don't forget about us; we're working on interesting things here in the desert.'

"We thought MR was the future. But the CT guys did one thing really well. They did an angiogram with an injection of a contrast agent, and the technology became much, much better.

"Radiologists and cardiologists basically do what they've always done, but they push a different button. And new software has it all come out in about two minutes.

"That's pretty easy compared to MR, where I have to take a course to learn cardiac MR because of the rules set down by the Society for Cardiovascular Magnetic Resonance (which I helped write).

"Why should anyone do all that when they already know how to take an x-ray picture? All they do is push a button and get the same kind of picture. That's one reason why CT angiography has a real advantage and why it is now ahead of MR angiography."

-Samuel A. Wickline, M.D., director of cardiovascular MRI and molecular imaging at Washington University School of Medicine in St. Louis, speaking at the molecular imaging users meeting of the International Society for Magnetic Resonance in Medicine meeting in May.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.